Brendon L. Neuen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease”.

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Stroke(2021)10.1161/strokeaha.120.031623

N/A

3.6DataRank · unranked

120 citations

Meg Jardine, Qiang Li, Brendon L. Neuen, Christopher P. Cannon, Dick de Zeeuw +95 more

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.15260920

N/A

3.4DataRank · unranked

54 citations

Zien Zhou, Hiddo J.L. Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal +18 more

Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.08780621

N/A

1.4DataRank · unranked

48 citations

Taha Sen, Clare Arnott, Bruce Neal, Jos G. W. Kosterink, Kenneth W. Mahaffey +9 more

Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials

Journal of the American Society of Nephrology(2023)10.1681/asn.0000000000000248

N/A

0.995DataRank · unranked

39 citations

Niels Jongs, Glenn M. Chertow, John J.V. McMurray, Clare Arnott, Meg Jardine +11 more

Cardiovascular and Renal Outcomes with Canagliflozin According to Baseline Diuretic Use: A Post Hoc Analysis from the CANVAS Program

ESC Heart Failure(2021)10.1002/ehf2.13236

N/A

0.967DataRank · unranked

23 citations

Clare Arnott, Brendon L. Neuen, Hiddo L. Heersprink, Kenneth W. Mahaffey, Christopher P. Cannon +11 more

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0.770DataRank · unranked

169 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

Association Between Circulating GDF‐15 and Cardio‐Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial

Journal of the American Heart Association(2021)10.1161/jaha.121.021661

N/A

0.524DataRank · unranked

32 citations

Jingwei Li, Brendon L. Neuen, Clare Arnott, Bruce Neal, Vlado Perkovic +6 more

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

Journal of the American Heart Association(2023)10.1161/jaha.122.028516

N/A

0.459DataRank · unranked

7 citations

Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan +13 more

Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial

Journal of the American Heart Association(2024)10.1161/jaha.123.031586

N/A

0.405DataRank · unranked

7 citations

Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S. Bajaj, G.B. John Mancini +9 more

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2025)10.1016/j.jchf.2025.03.042

N/A

0.325DataRank · unranked

7 citations

John W. Ostrominski, Brian Claggett, Brendon L. Neuen, Iris E. Beldhuis, Jawad H. Butt +14 more

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes

Diabetes Obesity and Metabolism(2020)10.1111/dom.14226

N/A

0DataRank · unranked

78 citations

Clare Arnott, Vlado Perkovic, Gemma A. Figtree, Dick de Zeeuw, Greg Fulcher +8 more

Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality

Kidney360(2025)10.34067/kid.0000000988

N/A

0DataRank · unranked

0 citations

Luke Buizen, Katie Harris, Sunil V. Badve, John Chalmers, Martin Gallagher +11 more

Chronic kidney disease

The Lancet(2021)10.1016/s0140-6736(21)00519-5

N/A

0DataRank · unranked

1410 citations

Tazeen H. Jafar, Dorothea Nitsch, Brendon L. Neuen, Vlado Perkovic, Kamyar Kalantar‐Zadeh

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

Diabetes Care(2022)10.2337/dc22-0866

N/A

0DataRank · unranked

58 citations

Meir Schechter, Taha Sen, Priya Vart, Brendon L. Neuen, Bruce Neal +7 more

Endothelin Receptor Antagonists and Risk of Heart Failure in CKD

JACC Heart Failure(2022)10.1016/j.jchf.2022.04.009

N/A

0DataRank · unranked

3 citations

Lesley A. Inker, Muthiah Vaduganathan, Brendon L. Neuen

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

Circulation(2023)10.1161/circulationaha.123.067584

N/A

0DataRank · unranked

312 citations

Hiddo J.L. Heerspink, Priya Vart, Brian Claggett, Robert A. Fletcher, Clare Arnott +11 more

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

Nature Medicine(2023)10.1038/s41591-023-02418-0

N/A

0DataRank · unranked

160 citations

Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Gerald B. Appel +79 more

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae132

N/A

0DataRank · unranked

79 citations

Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen +95 more

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials

Diabetes Care(2024)10.2337/dc23-1450

N/A

0DataRank · unranked

12 citations

David M. Charytan, Harpreet S. Bajaj, Adeera Levin, Navdeep Tangri, April Slee +6 more

A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection

Kidney International(2024)10.1016/j.kint.2024.05.024

N/A

0DataRank · unranked

12 citations

Devin Eddington, Juhi Chaudhari, Raymond O. Estacio, Enyu Imai, Marián Goicoechea +16 more

Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD

Kidney International Reports(2025)10.1016/j.ekir.2025.01.029

N/A

0DataRank · unranked

9 citations

Amanda Varghese, Sunil V. Badve, Roberto Pecoits‐Filho, Murilo Guedes, Clare Arnott +11 more